Industry News
NAZCA, Collaborative Fund and Others Invest USD11m in Chile’s Phage Labs
23 January 2024
Phage Labs, a Chilean biotech developing alternative disease treatments to control cattle sickness, raised a USD11m round from NAZCA, Collaborative Fund, Water Lemon Ventures and Kevin Efrusy (Accel).
You may be interested in...
-
Allianz in LatAm; Across Capital’s ~USD115m Final Close; JICA, DFC, IDB Lab Newest Fund Commitments
-
Nominations Open for LAVCA Deal Awards; BTG Pactual TIG Secures USD500m for Reforestation Strategy
-
Nominations Open for 2025 LAVCA Women Investors in Private Capital; New LAVCA Q3 Industry Data; Vinci Partners Acquires Controlling Stake in Outback’s Brazilian Operations
-
Allianz X Leads USD300m Series E for Argentina’s Ualá
Allianz X led a USD300m Series E for Argentina-based fintech Ualá, with participation...